EUVIMEDEUVIMED entdecken
Crossref

An injectable ROS-responsive hydrogel comprising chondroitin sulfate@resveratrol liposome package for osteoarthritis alleviation

Lamei Liu, Min Zhang, Yan Zhou, Lin He, Mingjian Chen, Yuchen Wu, Guanyu Yin, Hui He, Lanlin Qi, Bin Zhang, Xiaoxiao He, Kemin Wang

Biomaterials · 2026-04 · 327 · 123766

DOI: 10.1016/j.biomaterials.2025.123766 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biomaterials, 2026-04. Verfasst von Lamei Liu und 11 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Chemo and Biosensing, College of Biology, College of Chemistry and Chemical Engineering, Hunan University, Key Laboratory for…. Hauptthemen laut MEDLINE: Osteoarthritis, Reactive Oxygen Species, Hydrogels, Resveratrol. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 52 Literaturangaben. Gefördert von: National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Osteoarthritis (OA) is a complex and multifactorial joint disorder. Currently, there are few therapies to slow the progression of OA. Combining symptomatic slow-acting drugs and reactive oxygen species (ROS) scavenging reagents in the inflamed joint shows a promising therapeutic approach for OA. Nonetheless, the short residence time of free drugs in the joint cavity hinders their further application. Herein, an injectable composite of hydrogel and chondroitin sulfate@resveratrol liposome package (Gel/Lip@Res + Chs) was developed to improve drug residency ability and enable the simultaneous delivery of hydrophilic Chs and hydrophobic Res in the joint cavity. This injectable hydrogel, based on phenylboronic acid modified hyaluronic acid (HAPBA) and polyvinyl alcohol (PVA), provided ROS-responsive decomposition property and sustained drug release behavior, thereby effectively scavenging ROS, promoting macrophage repolarization, and decreasing the expression of inflammatory mediators and matrix-degrading enzymes in vitro. As a proof of concept, the in vivo therapeutic efficacy of Gel/Lip@Res + Chs was further examined in both monoiodoacetic acid (MIA)-induced and surgical anterior cruciate ligament transection (ACLT)-induced OA mouse models. Benefiting from the extended residence time of loaded drugs in the joint cavity, the Gel/Lip@Res + Chs treatment could effectively suppress cartilage degeneration and increase the synthesis of the cartilage matrix, thus slowing the advancement of OA. The present study provides a reference for improving drug retention and holds great potential for treating OA-related diseases.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

OsteoarthritisReactive Oxygen SpeciesHydrogelsResveratrolLiposomesChondroitin SulfatesAnimalsMiceMaleMice, Inbred C57BLRAW 264.7 CellsDrug Liberation

Stichwörter der Autor:innen

Cartilage degenerationLiposomeOsteoarthritisReactive oxygen speciesResponsive hydrogel

Substanzen

Reactive Oxygen SpeciesHydrogelsResveratrolLiposomesChondroitin Sulfates

Autor:innen und Institutionen

  • State Key Laboratory of Chemo and Biosensing, College of Biology, College of Chemistry and Chemical Engineering, Hunan University, Key Laboratory for Bio-Nanotechnology and Molecule Engineering of Hunan Province, Changs…

Förderung

  • National Natural Science Foundation of China

Zitieren

APA

Liu, L., Zhang, M., Zhou, Y., He, L., Chen, M., Wu, Y., Yin, G., He, H., Qi, L., Zhang, B., He, X., & Wang, K. (2026). An injectable ROS-responsive hydrogel comprising chondroitin sulfate@resveratrol liposome package for osteoarthritis alleviation. Biomaterials, 327, 123766. https://doi.org/10.1016/j.biomaterials.2025.123766

Vancouver

Liu L, Zhang M, Zhou Y, He L, Chen M, Wu Y, et al. An injectable ROS-responsive hydrogel comprising chondroitin sulfate@resveratrol liposome package for osteoarthritis alleviation. Biomaterials. 2026;327:123766. doi:10.1016/j.biomaterials.2025.123766

BibTeX
@article{Liu2026,
  author = {Liu, Lamei and Zhang, Min and Zhou, Yan and He, Lin and Chen, Mingjian and Wu, Yuchen and Yin, Guanyu and He, Hui and Qi, Lanlin and Zhang, Bin and He, Xiaoxiao and Wang, Kemin},
  title = {An injectable ROS-responsive hydrogel comprising chondroitin sulfate@resveratrol liposome package for osteoarthritis alleviation},
  journal = {Biomaterials},
  year = {2026},
  volume = {327},
  pages = {123766},
  doi = {10.1016/j.biomaterials.2025.123766}
}
Kostenlos starten →